Viewing nowPrisal Tablet 10mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Myung-In Pharmaceutical Co., Ltd.

MFDS item code 201103854 · Notified 2011.06.17 · Insurance code 651903520
Treatment of essential hypertension
This medication is a treatment that helps lower and maintain blood pressure within the normal range for essential hypertension. By doing so, it reduces the risk of cardiovascular diseases and contributes to the prevention of complications. This drug is used to effectively control blood pressure to maintain a healthy life for patients.
<Adults> The recommended initial dose is 10mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Older adults> No dose adjustment is required when administering this medicine to older adults aged 65 years or older. No overall differences in efficacy or safety have been observed between older and younger patients; however, the possibility of a more sensitive response in some older patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, which may be increased to a maximum of 20mg daily. Use is not recommended in patients with severe hepatic impairment because there is no experience with use in these patients.
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.
This drug can cause serious harm to the fetus and newborn if administered to pregnant women in the second and third trimesters, and in severe cases may lead to death. It is necessary to discontinue this medication immediately upon confirmation of pregnancy. This drug should not be used by patients who are allergic to its components, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver dysfunction, or patients with biliary obstruction. Also, patients with genetic issues such as lactose intolerance should not take this drug. Caution is required for patients with decreased blood volume or salt deficiency, as they may experience hypotension; in such cases, treatment should be started with careful observation of the condition. Patients with kidney function issues must regularly check serum potassium and creatinine levels, and it is not recommended for patients with severe kidney impairment. Special caution is needed when administering this drug to patients with aortic stenosis, mitral valve stenosis, and obstructive heart disease. Due to its blood pressure-lowering effects, this drug may cause dizziness; therefore, caution should be exercised when performing high-altitude work or driving. It is advisable not to use potassium-sparing diuretics or potassium supplements during the treatment with this drug, as the antihypertensive effect may be increased when used with other antihypertensive medications. When used together with lithium preparations, serum lithium levels may increase, leading to side effects, so it is safest to avoid combination therapy. Caution is also required as co-administration with non-steroidal anti-inflammatory drugs may worsen kidney function. If pregnant women take this drug, serious issues such as decreased kidney function, hypotension, anuria, and cranial skeletal development issues may occur, so it should be avoided during pregnancy. Nursing mothers should consider stopping breastfeeding or discontinuing this medication as it may be transmitted through breast milk. The safety and efficacy in children have not been established, so it is advisable not to use it in children. Overdose may cause hypotension and palpitations; if symptoms are severe, immediate medical attention should be sought. Although this drug is known to not increase cancer risk with long-term use, any abnormal symptoms during use should prompt consultation with a specialist.
Not everyone experiences these, and they can vary from person to person.
This drug must be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, avoid storing it in extremely hot or cold places, and it is important to store it at room temperature between 1 degree and 25 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
Myung-In Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.